We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWOU
2201
DELISTED
2U Inc
TWOU
$854K ﹤0.01%
4,157
+192
+5% +$48K
LAND
2202
Gladstone Land Corp
LAND
$360M
$853K ﹤0.01%
51,218
+158
+0.3% +$2.85K
FFIC
2203
DELISTED
Flushing Financial
FFIC
$849K ﹤0.01%
56,998
+847
+2% +$15.6K
NUVL
2204
DELISTED
Nuvalent
NUVL
$843K ﹤0.01%
32,315
+3,695
+13% +$109K
INBX
2205
DELISTED
Inhibrx, Inc. Common Stock
INBX
$841K ﹤0.01%
44,558
+3,354
+8% +$78K
UDMY
2206
DELISTED
Udemy
UDMY
$836K ﹤0.01%
94,700
+3,142
+3% +$33.1K
ASC icon
2207
Ardmore Shipping
ASC
$683M
$835K ﹤0.01%
56,123
-1,231
-2% -$19.3K
ITOS
2208
DELISTED
iTeos Therapeutics
ITOS
$834K ﹤0.01%
61,247
+3,025
+5% +$54.2K
DSEY
2209
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$834K ﹤0.01%
103,034
+5,298
+5% +$33.6K
MTTR
2210
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$830K ﹤0.01%
303,971
+8,730
+3% +$26.7K
NRC icon
2211
NRC Health Common Stock
NRC
$450M
$829K ﹤0.01%
19,059
+1,256
+7% +$55.5K
BZH icon
2212
Beazer Homes USA
BZH
$907M
$828K ﹤0.01%
52,120
+1,269
+2% +$18.8K
WOW
2213
DELISTED
WideOpenWest
WOW
$828K ﹤0.01%
77,909
+3,129
+4% +$33.9K
TELL
2214
DELISTED
Tellurian Inc.
TELL
$826K ﹤0.01%
671,931
+11,093
+2% +$17.7K
SRI icon
2215
Stoneridge
SRI
$213M
$825K ﹤0.01%
44,117
+1,410
+3% +$30.3K
PNT
2216
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$824K ﹤0.01%
113,324
+12,344
+12% +$91.6K
CAC icon
2217
Camden National
CAC
$976M
$820K ﹤0.01%
22,654
+499
+2% +$20.1K
YORW icon
2218
York Water
YORW
$514M
$820K ﹤0.01%
18,352
+514
+3% +$23K
FDMT icon
2219
4D Molecular Therapeutics
FDMT
$562M
$817K ﹤0.01%
47,501
+58
+0.1% +$1.13K
ALHC icon
2220
Alignment Healthcare
ALHC
$2.98B
$816K ﹤0.01%
128,361
+8,598
+7% +$82K
BOC icon
2221
Boston Omaha
BOC
$436M
$815K ﹤0.01%
34,416
+6
+0% +$149
ZYXI
2222
DELISTED
Zynex
ZYXI
$815K ﹤0.01%
67,881
+6,238
+10% +$81.5K
EVGO icon
2223
EVgo
EVGO
$229M
$812K ﹤0.01%
104,216
+3,962
+4% +$23.3K
PGC icon
2224
Peapack-Gladstone Financial
PGC
$812M
$812K ﹤0.01%
27,420
+706
+3% +$25K
BFC icon
2225
Bank First Corp
BFC
$1.7B
$810K ﹤0.01%
11,003
+36
+0.3% +$2.86K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.